[Congressional Record (Bound Edition), Volume 154 (2008), Part 16]
[Extensions of Remarks]
[Page 21988]
[From the U.S. Government Publishing Office, www.gpo.gov]




                          EARMARK DECLARATION

                                 ______
                                 

                       HON. CHRISTOPHER H. SMITH

                             of new jersey

                    in the house of representatives

                      Thursday, September 25, 2008

  Mr. SMITH of New Jersey. Madam Speaker, I submit the following:
  Requesting Member: Rep. Christopher H. Smith
  Bill Number: HR 2638.
  Account: Research, Development, Test and Evaluation, Defense-wide 
Account.
  Legal Name of Requesting Entity: the Gallo Prostate Cancer Center, 
University of Medicine and Dentistry of New Jersey.
  Address of Requesting Entity: Cancer Institute of New Jersey, 195 
Little Albany & Somerset St., Room 2002, Newark, NJ 08901-1998.
  Description of Request: Funding support is requested for key projects 
for the Cancer Institute of New Jersey to address national goal of 
eradicating cancer, including prostate cancer which is the second 
leading cause of cancer death in American men. Our proposed initiatives 
are The Dean and Betty Gallo Prostate Cancer Center, which seeks to 
eradicate prostate cancer through research, treatment, education and 
prevention; the Center for Imaging, Structures and Function, which will 
provide state of the art image analysis crucial to the overall 
applications of cancer research; a Center for Cancer Bioinformatics, 
which combines theoretical biology, computer science, mathematics and 
physics with cancer research expertise; the LIFE Center, which 
coordinates efforts in the eradication of breast cancer; and our plans 
to merge and enhance the radiation oncology capabilities to create a 
unified, academically and clinically strong program for the citizens of 
New Jersey.
  By targeting breast and prostate cancer, through developing novel 
cancer bioinformatics approaches to identify new biomarkers for therapy 
and prevention and through developing new technologies and approaches 
in molecular imaging, computational, informatics and systems biology, 
this project will contribute to the national goals of the elimination 
of death and suffering from cancer and to the enhanced discovery, 
development and delivery of novel means of cancer diagnosis, prevention 
and treatment.
  Detailed Financial Plan:
  The total cost of this program has been valued at $2.4 million and 
funding will go toward:
  1. Personnel Costs: $1,339,990.
  2. Equipment: $643,197.
  ABI Prism 7900 HT with Robot (SNP analysis): $126,275.
  Web and Database Servers: $6,991.
  Micro PET, CT, High speed cell sorters: $249,942.
  Confocal Microscope. Lasers, workstations: $196,622.
  Computer pilot modules for testing: $758.
  Video conference equipments for case research: $62,609.
  3. Consultant Costs: $28,756.
  4. Supplies: $153,934.
  Molecular Biology Reagents, antibodies, cell culture reagents, animal 
costs, chemicals, dissecting instruments: $97,520.
  Flourescent labeled primers, enzymes, PCR kits: $4,240.
  Invitrogen, well plates, cell lifters, toxins, lab and chemical 
supplies: $52,174.
  5. Travel for Principal Investigators: $14,298.
  6. Other Expenses: $219,825.

                          ____________________